2-[3-(2-Dimethylamino-5-trifluoromethyl-pyridin-3-yl)-phenoxy]-propionic acid ethyl ester, 95.0%, 5g

(1R,3aR,7aR)-1-((2R,5S,E)-5,6-dimethyl-6-((triethylsilyl)oxy)hept-3-en-2-yl)-7a-methylhexahydro-1H-inden-4(2H)-one, 98%, 25mg

N-(4-Methyl-3-nitrophenyl)methanesulfonamide, 95+%, 500mg

N-[3-[4,5-Dihydro-4-methyl-6-[[4-(4-morpholinylcarbonyl)phenyl]amino]-5-oxo-2-pyrazinyl]-2-methylphenyl]-4-(1,1-dimethylethyl)benzamide, 98%, 5mg

6-Fluoro-4-methylquinoline, 95+%, 5g

Réservoirs de zone Toutes couches, 850 mm, acier inoxydable 1.4404, 1 pièce

(S)-2-((ethoxycarbonyl)amino)-3,3-dimethylbutanoic acid, 97%, 100mg

4-allyl-5-(3,4-dichlorophenyl)-4H-1,2,4-triazole-3-thiol, 95.0%, 1g

Bromure de manganèse(II), tétrahydraté 98 % 50 g

1,2,3,4-Tetrahydroisoquinoline-3-carboxylic acid, 95.0%, 500g

TERT-BUTYL 6,7-DIHYDROPYRAZOLO[1,5-A]PYRAZINE-5(4H)-CARBOXYLATE, 95.0%, 250mg

2,6-Bis(4,5-dihydrooxazol-2-yl)pyridine, 95.0%, 5g

3,3-DIFLUOROPIPERIDIN-2-ONE, 97.0%, 1g